Impaired Fasting Glucose and Impaired Glucose Tolerance
Massachusetts General Hospital · Harvard University · +7 more institutions
Abstract
Type 2 diabetes is now epidemic. In the U.S., there has been a 61% increase in incidence between 1990 and 2001 (1). There are currently 1.5 million new cases per year, and the prevalence in 2005 was almost 21 million (2). The epidemic has affected developed and developing countries alike, and the worldwide prevalence of diabetes is projected to increase dramatically by 2025 (3). The increase in type 2 diabetes is related to lifestyle changes that have resulted in overweight, obesity, and decreased physical activity levels. These environmental changes, superimposed on genetic predisposition, increase insulin resistance, which, in concert with progressive β-cell failure, results in rising glycemia in the…
Citation impact
- FWCI
- 40.11
- Percentile
- 100%
- References
- 58
Authors
7- DMDavid M. NathanCorresponding
Massachusetts General Hospital, Harvard University
- MBMayer B. Davidson
Charles R. Drew University of Medicine and Science
- RARalph A. DeFronzo
The University of Texas Health Science Center at San Antonio
- RJRobert J. Heine
Amsterdam UMC Location VUmc
- RRRobert R. Henry
University of California, San Diego
Topics & keywords
- Medicine
- Impaired glucose tolerance
- Impaired fasting glucose
- Diabetes mellitus
- Internal medicine
- Endocrinology
- Glucose tolerance test
- Type 2 diabetes
- Good health and well-being